A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma

References

• Vos T, Allen C, Arora M, et al.; GBD 2017 Disease Injury Incidence Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1789–1858.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Viinanen A, Lassenius MI, Toppila I, et al. The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization. J Asthma. 2020;57:1092–1102. doi:10.1080/02770903.2019.1633664
   PubMed Web of Science ®Google Scholar
• Shantakumar S, Ho YF, Beale J, Gribben B. Characterization and burden of severe eosinophilic asthma in New Zealand: results from the HealthStat Database. Multidiscip Respir Med. 2020;15:662. doi:10.4081/mrm.2020.662
   PubMed Web of Science ®Google Scholar
• Demarche SF, Schleich FN, Paulus VA, Henket MA, Van Hees TJ, Louis RE. Asthma control and sputum eosinophils: a longitudinal study in daily practice. J Allergy Clin Immunol Pract. 2017;5:1335–43 e5. doi:10.1016/j.jaip.2017.01.026
   PubMed Web of Science ®Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al.; Group UBS. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46:1308–1321. doi:10.1183/13993003.00779-2015
   PubMed Web of Science ®Google Scholar
• Pavord ID. Eosinophilic phenotypes of airway disease. Ann Am Thorac Soc. 2013;10:S143–9. doi:10.1513/AnnalsATS.201306-168AW
   PubMedGoogle Scholar
• Walsh CJ, Zaihra T, Benedetti A, et al. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils. Clin Exp Allergy. 2016;46:1291–1302. doi:10.1111/cea.12762
   PubMed Web of Science ®Google Scholar
• Heaney LG, Perez de Llano L, Al-Ahmad M, et al. Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort. Chest. 2021;160:814–830. doi:10.1016/j.chest.2021.04.013
   PubMed Web of Science ®Google Scholar
• Dean BB, Calimlim BC, Sacco P, Aguilar D, Maykut R, Tinkelman D. Uncontrolled asthma: assessing quality of life and productivity of children and their caregivers using a cross-sectional Internet-based survey. Health Qual Life Outcomes. 2010;8:96. doi:10.1186/1477-7525-8-96
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2018. Available from: https://ginasthma.org/wp-content/uploads/2019/01/8-GINA.pdf. Accessed June 29, 2022.
   Google Scholar
• Chen S, Golam S, Myers J, Bly C, Smolen H, Xu X. Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Curr Med Res Opin. 2018;34:2075–2088. doi:10.1080/03007995.2018.1505352
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. 2022;386:157–171. doi:10.1056/NEJMra2032506
   PubMed Web of Science ®Google Scholar
• Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev. 2017;278:162–172. doi:10.1111/imr.12557
   PubMed Web of Science ®Google Scholar
• McCormick JP, Lee JT. Insights into the Implications of Coexisting Type 2 Inflammatory Diseases. J Inflamm Res. 2021;14:4259–4266. doi:10.2147/JIR.S311640
   PubMed Web of Science ®Google Scholar
• Caminati M, Pham DL, Bagnasco D, Canonica GW. Type 2 immunity in asthma. World Allergy Organ J. 2018;11:13. doi:10.1186/s40413-018-0192-5
   PubMed Web of Science ®Google Scholar
• Chung KF, Dixey P, Abubakar-Waziri H, et al. Characteristics, phenotypes, mechanisms and management of severe asthma. Chin Med J. 2022;135:1141–1155. doi:10.1097/CM9.0000000000001990
   PubMed Web of Science ®Google Scholar
• Pavord ID, Hanania NA, Corren J. Controversies in allergy: choosing a biologic for patients with severe asthma. J Allergy Clin Immunol Pract. 2022;10:410–419. doi:10.1016/j.jaip.2021.12.014
   PubMed Web of Science ®Google Scholar
• Wang G, Wang F, Gibson PG, et al. Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian Severe Asthma Network. J Thorac Dis. 2017;9:1333–1344. doi:10.21037/jtd.2017.04.74
   PubMed Web of Science ®Google Scholar
• Nagasaki T, Sato K, Kume N, et al. The prevalence and disease burden of severe eosinophilic asthma in Japan. J Asthma. 2019;56:1147–1158. doi:10.1080/02770903.2018.1534967
   PubMed Web of Science ®Google Scholar
• Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018;197:22–37. doi:10.1164/rccm.201611-2232PP
   PubMed Web of Science ®Google Scholar
• Carosso A, Bugiani M, Migliore E, Anto JM, DeMarco R. Reference values of total serum IgE and their significance in the diagnosis of allergy in young European adults. Int Arch Allergy Immunol. 2007;142:230–238. doi:10.1159/000097025
   PubMed Web of Science ®Google Scholar
• Husereau D, Goodfield J, Leigh R, Borrelli R, Cloutier M, Gendron A. Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data. Allergy Asthma Clin Immunol. 2018;14:15. doi:10.1186/s13223-018-0241-1
   PubMed Web of Science ®Google Scholar
• Denton E, Price DB, Tran TN, et al. Cluster analysis of inflammatory biomarker expression in the international severe asthma registry. J Allergy Clin Immunol Pract. 2021;9:2680–8 e7. doi:10.1016/j.jaip.2021.02.059
   PubMed Web of Science ®Google Scholar
• Cheng SL, Chiu KC, Ko HK, et al. Comparing patient characteristics, clinical outcomes, and biomarkers of severe asthma patients in Taiwan. Biomedicines. 2021;9:764. doi:10.3390/biomedicines9070764
   PubMed Web of Science ®Google Scholar
• Tran TN, Zeiger RS, Peters SP, et al. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma. Ann Allergy Asthma Immunol. 2016;116:37–42. doi:10.1016/j.anai.2015.10.027
   PubMed Web of Science ®Google Scholar
• Vignola AM, Chanez P, Chiappara G, et al. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol. 1999;103:563–573. doi:10.1016/S0091-6749(99)70225-3
   PubMed Web of Science ®Google Scholar
• Poddighe D, Mathias CB, Brambilla I, Marseglia GL, Oettgen HC. Importance of basophils in eosinophilic asthma: the murine counterpart. J Biol Regul Homeost Agents. 2018;32:335–339.
   PubMed Web of Science ®Google Scholar
• Mathias CB, Freyschmidt EJ, Caplan B, et al. IgE influences the number and function of mature mast cells, but not progenitor recruitment in allergic pulmonary inflammation. J Immunol. 2009;182:2416–2424. doi:10.4049/jimmunol.0801569
   PubMed Web of Science ®Google Scholar
• Kraft M, Brusselle G, FitzGerald JM, et al. Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma. Eur Respir J. 2021;58:2100413. doi:10.1183/13993003.00413-2021
   PubMed Web of Science ®Google Scholar
• Broekema M, Volbeda F, Timens W, et al. Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1). Respir Med. 2010;104:1254–1262. doi:10.1016/j.rmed.2010.03.030
   PubMed Web of Science ®Google Scholar
• Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosinophils in allergic airways remodeling. Science. 2004;305:1776–1779. doi:10.1126/science.1100283
   PubMed Web of Science ®Google Scholar
• Yang YC, Zhang N, Van Crombruggen K, Hu GH, Hong SL, Bachert C. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy. 2012;67:1193–1202. doi:10.1111/j.1398-9995.2012.02880.x
   PubMed Web of Science ®Google Scholar
• Kardas G, Daszynska-Kardas A, Marynowski M, Brzakalska O, Kuna P, Panek M. Role of Platelet-Derived Growth Factor (PDGF) in asthma as an immunoregulatory factor mediating airway remodeling and possible pharmacological target. Front Pharmacol. 2020;11:47. doi:10.3389/fphar.2020.00047
   PubMed Web of Science ®Google Scholar
• Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000;161:9–16. doi:10.1164/ajrccm.161.1.9802048
   PubMed Web of Science ®Google Scholar
• Shaw DE, Berry MA, Hargadon B, et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest. 2007;132:1871–1875. doi:10.1378/chest.07-1047
   PubMed Web of Science ®Google Scholar
• Han YY, Forno E, Celedon JC. Sex steroid hormones and asthma in a nationwide study of U.S. adults. Am J Respir Crit Care Med. 2020;201:158–166. doi:10.1164/rccm.201905-0996OC
   PubMed Web of Science ®Google Scholar
• Senna G, Latorre M, Bugiani M, et al. Sex differences in severe asthma: results from severe asthma network in Italy-SANI. Allergy Asthma Immunol Res. 2021;13:219–228. doi:10.4168/aair.2021.13.2.219
   PubMed Web of Science ®Google Scholar
• Chowdhury NU, Guntur VP, Newcomb DC, Wechsler ME. Sex and gender in asthma. Eur Respir Rev. 2021;30:210067. doi:10.1183/16000617.0067-2021
   PubMed Web of Science ®Google Scholar